PRN: 2011 Health Conditions for Travel to Mecca (Hajj) Pilgrimage Published

23/ago/2011 11.21.48 PR Newswire Turismo Contatta l'autore

Questo comunicato è stato pubblicato più di 1 anno fa. Le informazioni su questa pagina potrebbero non essere attendibili.

2011 Health Conditions for Travel to Mecca (Hajj) Pilgrimage Published

 
[23-August-2011]
 

AMMAN, Jordan, August 23, 2011 /PRNewswire/ --

Saudi Ministry of Health issues the entry visa requirements and recommendations for the Hajj and Umra season in 2011

Elsevier, the world's leading provider of scientific, technical and medical information products and services, announced today that the Saudi Ministry of Health has published its 2011 health conditions for travelers to the Kingdom of Saudi Arabia for the pilgrimage to Mecca (Hajj). The publication, published in the August Issue of Journal of Infection and Public Health (JIPH), informs visitors of the full requirements for entry into Saudi Arabia.

The Saudi Ministry of Health plays a critical role in the management of the annual Hajj pilgrimage which occurs over a five-day period during "Dhul-Hijjah," the final month of the Islamic calendar and is the world's largest annual mass gathering, attracting 2-3 million pilgrims every year.

Travelers are urged to read the guidelines in their entirety, the highlights of which are as follows:  

  • Yellow Fever: All travelers arriving from countries or areas at risk of yellow fever must present a valid yellow fever vaccination certificate showing that the person was vaccinated at least 10 days previously and not more than 10 years before arrival at the border.
  • Meningococcal Meningitis: Visitors arriving for the purpose of Umra or pilgrimage or for seasonal work are required to produce a certificate of vaccination with the quadrivalent (ACYW135) vaccine against meningitis issued not more than 3 years previously and not less than 10 days before arrival in to Saudi Arabia.
  • Poliomyelitis: All travelers arriving from polio-endemic countries and re-established transmission countries should receive 1 dose of OPV.
  • Seasonal Influenza: International pilgrims should be vaccinated against seasonal influenza before arrival into Saudi Arabia with WHO approved strains specific to the northern or southern hemispheres. In Saudi Arabia, seasonal influenza vaccine is recommended for internal pilgrims, particularly those with pre-existing health conditions, and all staff working in the Hajj premises.
  • Health Education: Health authorities in countries of origin are required to provide information to pilgrims on infectious diseases symptoms, methods of transmission, complications, and means of prevention.
  • Food: Hajj and Umra performers are not allowed to bring fresh food in to Saudi Arabia. Only properly canned or sealed food or food stored in containers with easy access for inspection is allowed in small quantities, sufficient for one person for the duration of his or her trip.
  • International Outbreaks Responses: Updating immunization against vaccine-preventable diseases in all travelers is strongly recommended.

"The Department of Preventive Medicine at the Ministry of Health develops and updates these guidelines every year in close coordination with the International Health Regulations Coordination Department at WHO. This is carried out after critical review of the global situation of endemic and emerging communicable diseases, to ensure the establishment of evidence based guidelines to protect and prevent disease transmission among pilgrims and the global community," stated His Excellency Dr. Abdullah Al Rabeeah, Saudi Minister of Health. "These guidelines are then disseminated through the Saudi Ministry of Foreign Affairs to all the countries and enforced through the respective Royal Saudi Embassy in each country of origin and checked at all ports of entry into Saudi Arabia by Ministry of Health Preventive Medicine staff."

Notes to editors

The full article, Health conditions for travelers to Saudi Arabia for the pilgrimage to Mecca (Hajj) 1432 (2011), is authored by Ziad A. Memishand Abdullah A. Al Rabeeah, with theSaudi Ministry of Health, Riyadh, Kingdom of Saudi Arabia, Journal of Infection and Public Health Volume 4, Issue 3, August 2011, Pages 105-107, doi:10.1016/j.jiph.2011.07.001. The full article can be accessed free of charge on the journal's website, http://www.jiph.org. In addition, the report will be re-published in the World Epidemiological Record in September 2011.

About Journal of Infection and Public Health

Journal of Infection and Public Health is the official journal of the Saudi Arabian National Guard Health Affairs, King Saud Bin Abdulaziz University for Health Sciences and the Saudi Association for Public Health. The journal aims to be the foremost scientific, peer-reviewed journal encompassing infection prevention and control, microbiology, infectious diseases, public health and the application of healthcare epidemiology to the evaluation of health outcomes. The point of view of the journal is that infection and public health are closely intertwined and that advances in one area will have positive consequences on the other.

About Elsevier


Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include SciVerse ScienceDirect, SciVerse Scopus, Reaxys, MD Consult and Nursing Consult, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai's Pinpoint Review, which help research and health care instit! utions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Media contact
Anne Marie Pordon
Elsevier
+962-6-533-3321
a.pordon@elsevier.com 



Company Codes: LSE:REL, NYSE:RUK, NYSE:ENL
blog comments powered by Disqus
Comunicati.net è un servizio offerto da Factotum Srl